At the heart of Poseida’s gene and cell therapy programs are its genome engineering technologies. Poseida is dedicated to using its genome engineering technologies to develop targeted therapeutics for patients.
Gene Therapy Applications
Combining the high-efficiency and stable, high-level expression characteristics of piggyBac™ with the in vivo delivery capabilities of non-integrative viral vectors, Poseida’s unique hybrid gene therapy system is ideal for permanent correction of genetic diseases.
CAR-T and Cell Therapy Applications
Poseida creates it’s CAR-T therapies unlike any other company. Other companies use retroviruses, such as lentivirus. Poseida’s piggyBac™ system is safer and more efficient than retroviral systems. Poseida also uses its genome engineering technologies to make its cell therapies safer and to reduce side effects.